2 posts tagged by Digg
World & Business
Ivonescimab plus chemotherapy delayed progression but did not demonstrate a statistically significant overall-survival improvement in the primary analysis.
Science
A science and health roundup highlights the reported survival benefit alongside other lung cancer results, including a combination therapy that missed its endpoints.
